Calcium signaling and the therapeutic targeting of cancer cells.
暂无分享,去创建一个
[1] A. Florea,et al. Co-application of arsenic trioxide (As2O3) and cisplatin (CDDP) on human SY-5Y neuroblastoma cells has differential effects on the intracellular calcium concentration ([Ca2+]i) and cytotoxicity. , 2009, Neurotoxicology.
[2] M. Berridge. The AM and FM of calcium signalling , 1997, Nature.
[3] Sarah J. Roberts-Thomson,et al. Store-Independent Activation of Orai1 by SPCA2 in Mammary Tumors , 2010, Cell.
[4] N. Prevarskaya,et al. Calcium in tumour metastasis: new roles for known actors , 2011, Nature Reviews Cancer.
[5] Thomas R. Cox,et al. Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.
[6] J. Larner,et al. T-Type Ca2+ Channel Inhibition Induces p53-Dependent Cell Growth Arrest and Apoptosis through Activation of p38-MAPK in Colon Cancer Cells , 2013, Molecular Cancer Research.
[7] D. Ingber,et al. Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy , 2015, Oncogene.
[8] F. Mammano,et al. p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner , 2015, Proceedings of the National Academy of Sciences.
[9] Souleymane Abdoul-Azize,et al. Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation , 2017, Oncotarget.
[10] R. Weinberg,et al. EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling , 2017, Proceedings of the National Academy of Sciences.
[11] G. Barritt,et al. Evidence that TRPM8 Is an Androgen-Dependent Ca2+ Channel Required for the Survival of Prostate Cancer Cells , 2004, Cancer Research.
[12] James Hicks,et al. Unravelling biology and shifting paradigms in cancer with single-cell sequencing , 2017, Nature Reviews Cancer.
[13] S. Lakhani,et al. Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor–Negative Breast Cancer , 2012, Molecular Cancer Therapeutics.
[14] T. Putti,et al. TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein , 2017, Oncogenesis.
[15] Kevin D. Nullmeyer,et al. Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines. , 2005, Cancer research.
[16] H. Llewelyn Roderick,et al. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival , 2008, Nature Reviews Cancer.
[17] M. Pagano,et al. PTEN counteracts FBXL2 to promote IP3R3– and Ca2+–mediated apoptosis limiting tumour growth , 2017, Nature.
[18] J. Diehl,et al. Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria. , 2016, Cell reports.
[19] L. Gray,et al. T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin , 2016, Molecular Cancer Therapeutics.
[20] J. Parys,et al. Bcl-2 proteins and calcium signaling: complexity beneath the surface , 2016, Oncogene.
[21] Ji-Eun Lee,et al. Mitochondrial Hsp90s suppress calcium-mediated stress signals propagating from mitochondria to the ER in cancer cells , 2014, Molecular Cancer.
[22] M. Bissell,et al. An “elite hacker” , 2012, Cell adhesion & migration.
[23] Jian Jin,et al. Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells. , 2014, Biochemical and biophysical research communications.
[24] J. Putney,et al. Emerging perspectives in store-operated Ca2+ entry: roles of Orai, Stim and TRP. , 2006, Biochimica et biophysica acta.
[25] Kechun Zhou,et al. Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer , 2009, Gut.
[26] Huiling Liu,et al. Calcium entry via ORAI1 regulates glioblastoma cell proliferation and apoptosis. , 2011, Experimental and molecular pathology.
[27] M. Hoth,et al. Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells. , 2013, Biochimica et biophysica acta.
[28] C. Romanin,et al. TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival , 2014, Proceedings of the National Academy of Sciences.
[29] A. Parekh,et al. Distinct Spatial Ca2+ Signatures Selectively Activate Different NFAT Transcription Factor Isoforms , 2015, Molecular cell.
[30] P A Kenny,et al. Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells , 2017, Oncogene.
[31] T. Wieland,et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension , 2013, Nature Genetics.
[32] H. Sevestre,et al. Down‐regulation of Orai3 arrests cell‐cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells , 2011, Journal of cellular physiology.
[33] N. Prevarskaya,et al. The role of the TRPV6 channel in cancer , 2012, The Journal of physiology.
[34] Ye Xu,et al. Calcium efflux from the endoplasmic reticulum regulates cisplatin-induced apoptosis in human cervical cancer HeLa cells , 2016, Oncology letters.
[35] M. Hediger,et al. Tamoxifen Inhibits TRPV6 Activity via Estrogen Receptor–Independent Pathways in TRPV6-Expressing MCF-7 Breast Cancer Cells , 2009, Molecular Cancer Research.
[36] I. Azimi,et al. TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells , 2017, Journal of Cell Science.
[37] Kechun Zhou,et al. Transient receptor potential channel C3 contributes to the progression of human ovarian cancer , 2009, Oncogene.
[38] E. Petricoin,et al. Targetable T-type Calcium Channels Drive Glioblastoma. , 2017, Cancer research.
[39] Julie Gehl,et al. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. , 2012, Cancer research.
[40] Laura Tociu,et al. Transmembrane helix connectivity in Orai1 controls two gates for calcium-dependent transcription , 2017, Science Signaling.
[41] S. Piha-Paul,et al. First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors , 2017, Investigational New Drugs.
[42] P. Kenny,et al. ORAI1-Mediated Calcium Influx in Lactation and in Breast Cancer , 2011, Molecular Cancer Therapeutics.
[43] E. Thompson,et al. Targeting EMT in cancer: opportunities for pharmacological intervention. , 2014, Trends in pharmacological sciences.
[44] Genee Y. Lee,et al. Targeting the tumor microenvironment. , 2007, Frontiers in bioscience : a journal and virtual library.
[45] J. Gehl,et al. Normal and Malignant Cells Exhibit Differential Responses to Calcium Electroporation. , 2017, Cancer research.
[46] Minyong Li,et al. Store-operated CRAC channel inhibitors: opportunities and challenges. , 2016, Future medicinal chemistry.
[47] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[48] J. Pearson,et al. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance , 2015, The Journal of pathology.
[49] Jian Jin,et al. TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway , 2017, Scientific Reports.
[50] H. Sevestre,et al. Orai3 Constitutes a Native Store-Operated Calcium Entry That Regulates Non Small Cell Lung Adenocarcinoma Cell Proliferation , 2013, PloS one.
[51] Ivacaftor , 2018, Reactions Weekly.
[52] Xin-Yun Huang,et al. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. , 2009, Cancer cell.
[53] Jia-guo Zhou,et al. Inhibition of Orai1‐mediated Ca2+ entry enhances chemosensitivity of HepG2 hepatocarcinoma cells to 5‐fluorouracil , 2016, Journal of cellular and molecular medicine.
[54] G. Lepage,et al. Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. , 2014, Biochimica et biophysica acta.
[55] Tudor I. Oprea,et al. A comprehensive map of molecular drug targets , 2016, Nature Reviews Drug Discovery.
[56] D. F. Chedom,et al. Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche. , 2016, Cancer cell.
[57] Chun-you Wang,et al. ASIC1 and ASIC3 contribute to acidity-induced EMT of pancreatic cancer through activating Ca2+/RhoA pathway , 2017, Cell Death & Disease.
[58] G. Santoni,et al. Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents. , 2013, Carcinogenesis.
[59] Min Zhang,et al. MICU1 drives glycolysis and chemoresistance in ovarian cancer , 2017, Nature Communications.
[60] T. Liang,et al. Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent , 2016, Scientific Reports.
[61] Xu Sun,et al. Increasing circulating exosomes‐carrying TRPC5 predicts chemoresistance in metastatic breast cancer patients , 2017, Cancer science.
[62] Zhenyu Xu,et al. Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells , 2012, Proceedings of the National Academy of Sciences.
[63] F. Mammano,et al. Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling , 2014, Oncotarget.
[64] W. Berger,et al. The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells , 2017, International journal of cancer.
[65] F. Zufall,et al. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity , 2018, The Journal of physiology.
[66] B. Bussolati,et al. TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling , 2012, Oncogene.
[67] S. Feske,et al. Emerging roles of store-operated Ca2+ entry through STIM and ORAI proteins in immunity, hemostasis and cancer , 2013, Channels.
[68] M. Ewen,et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.
[69] N. Prevarskaya,et al. Targeting Ca2+ transport in cancer: close reality or long perspective? , 2013, Expert opinion on therapeutic targets.
[70] M. Edelmann,et al. Altered Ca-Homeostasis of Cisplatin-Treated and Low Level Resistant Non-Small-Cell and Small-Cell Lung Cancer Cells , 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[71] N. Perrimon,et al. Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer. , 2013, Cancer cell.
[72] Daozhen Chen,et al. Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance , 2014, Proceedings of the National Academy of Sciences.
[73] Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection , 2018, Cell Death & Differentiation.
[74] L. Hazlehurst,et al. Tipifarnib-Induced Apoptosis in Acute Myeloid Leukemia and Multiple Myeloma Cells Depends on Ca2+ Influx through Plasma Membrane Ca2+ Channels , 2011, Journal of Pharmacology and Experimental Therapeutics.
[75] J. Diehl,et al. Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria. , 2016, Cell reports.
[76] S. Lakhani,et al. The calcium pump plasma membrane Ca2+-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin , 2016, Scientific Reports.
[77] S. Huber,et al. Targeting TRPM2 Channels Impairs Radiation-Induced Cell Cycle Arrest and Fosters Cell Death of T Cell Leukemia Cells in a Bcl-2-Dependent Manner , 2015, Oxidative medicine and cellular longevity.
[78] G. Monteith,et al. Genetically Encoded Calcium Indicators as Probes to Assess the Role of Calcium Channels in Disease and for High-Throughput Drug Discovery. , 2017, Advances in pharmacology.
[79] Jian Jin,et al. Inhibition of Transient Receptor Potential Channel 5 Reverses 5-Fluorouracil Resistance in Human Colorectal Cancer Cells* , 2014, The Journal of Biological Chemistry.
[80] Fei Zou,et al. STIM1 and STIM2 differently regulate endogenous Ca2+ entry and promote TGF-β-induced EMT in breast cancer cells. , 2017, Biochemical and biophysical research communications.
[81] F. Beuschlein,et al. Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3. , 2016, Endocrinology.
[82] N. Prevarskaya,et al. The calcium–cancer signalling nexus , 2017, Nature Reviews Cancer.
[83] N. Prevarskaya,et al. Role of TRP ion channels in cancer and tumorigenesis , 2016, Seminars in Immunopathology.
[84] C. Cantí,et al. T-type Ca2+ Channels: T for Targetable. , 2018, Cancer research.
[85] G. Semenza,et al. Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment. , 2017, Cell reports.
[86] G. Wilding,et al. Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours , 2016, British Journal of Cancer.
[87] Melissa A. Brown,et al. The voltage gated Ca2+-channel Cav3.2 and therapeutic responses in breast cancer , 2016, Cancer Cell International.
[88] N. Prevarskaya,et al. Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks? , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[89] P. Kenny,et al. Distinct Regulation of Cytoplasmic Calcium Signals and Cell Death Pathways by Different Plasma Membrane Calcium ATPase Isoforms in MDA-MB-231 Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.
[90] Jungil Choi,et al. Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R , 2016, Molecular Cancer Therapeutics.
[91] P. A. Friedman,et al. PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer , 2016, Proceedings of the National Academy of Sciences.
[92] R. Tsien,et al. CaV1 and CaV2 Channels Engage Distinct Modes of Ca2+ Signaling to Control CREB-Dependent Gene Expression , 2012, Cell.
[93] D. Clapham,et al. Calcium Signaling , 2007, Cell.
[94] Tullio Pozzan,et al. Enjoy the Trip: Calcium in Mitochondria Back and Forth. , 2016, Annual review of biochemistry.
[95] Kees Jalink,et al. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent , 2013, Oncogene.
[96] A. Rosato,et al. The mitochondrial calcium uniporter regulates breast cancer progression via HIF‐1α , 2016, EMBO molecular medicine.
[97] M. Bastmeyer,et al. TRPM8 is required for survival and radioresistance of glioblastoma cells , 2017, Oncotarget.
[98] K. Tarte,et al. Localized Store-Operated Calcium Influx Represses CD95-Dependent Apoptotic Effects of Rituximab in Non-Hodgkin B Lymphomas , 2015, The Journal of Immunology.
[99] William C Hines,et al. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.
[100] C. Stournaras,et al. Enhanced Orai1 and STIM1 expression as well as store operated Ca2+ entry in therapy resistant ovary carcinoma cells , 2014, Oncotarget.
[101] B. Zhivotovsky,et al. 5-Fluorouracil signaling through a calcium–calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells , 2013, Oncogene.
[102] M. Hoth. CRAC channels, calcium, and cancer in light of the driver and passenger concept. , 2016, Biochimica et biophysica acta.
[103] N. Prevarskaya,et al. TRPV6 channel controls prostate cancer cell proliferation via Ca2+/NFAT-dependent pathways , 2007, Oncogene.